
Jennifer Doan
Examiner (ID: 2317, Phone: (571)272-2346 , Office: P/2883 )
| Most Active Art Unit | 2874 |
| Art Unit(s) | 2883, 2874 |
| Total Applications | 1999 |
| Issued Applications | 1770 |
| Pending Applications | 114 |
| Abandoned Applications | 149 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5632351
[patent_doc_number] => 20060148821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'N,N-disubstituted diazocycloalkanes'
[patent_app_type] => utility
[patent_app_number] => 11/364653
[patent_app_country] => US
[patent_app_date] => 2006-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16095
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148821.pdf
[firstpage_image] =>[orig_patent_app_number] => 11364653
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/364653 | N,N-disubstituted diazocycloalkanes | Feb 26, 2006 | Abandoned |
Array
(
[id] => 5632346
[patent_doc_number] => 20060148816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => '17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases'
[patent_app_type] => utility
[patent_app_number] => 11/362217
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9112
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148816.pdf
[firstpage_image] =>[orig_patent_app_number] => 11362217
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/362217 | 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | Feb 23, 2006 | Issued |
Array
(
[id] => 5656633
[patent_doc_number] => 20060142369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Delta 1-pyrrolines used as pesticides'
[patent_app_type] => utility
[patent_app_number] => 11/360134
[patent_app_country] => US
[patent_app_date] => 2006-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22133
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142369.pdf
[firstpage_image] =>[orig_patent_app_number] => 11360134
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/360134 | Delta 1-pyrrolines used as pesticides | Feb 22, 2006 | Abandoned |
Array
(
[id] => 7597492
[patent_doc_number] => 07619085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-17
[patent_title] => 'Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine'
[patent_app_type] => utility
[patent_app_number] => 11/817320
[patent_app_country] => US
[patent_app_date] => 2006-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3123
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/619/07619085.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817320
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817320 | Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine | Feb 22, 2006 | Issued |
Array
(
[id] => 4624492
[patent_doc_number] => 08003790
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-23
[patent_title] => 'Salt of proline derivative, solvate thereof, and production method thereof'
[patent_app_type] => utility
[patent_app_number] => 11/816493
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9471
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/003/08003790.pdf
[firstpage_image] =>[orig_patent_app_number] => 11816493
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/816493 | Salt of proline derivative, solvate thereof, and production method thereof | Feb 16, 2006 | Issued |
Array
(
[id] => 4949920
[patent_doc_number] => 20080306046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Derivative'
[patent_app_type] => utility
[patent_app_number] => 11/816508
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66968
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306046.pdf
[firstpage_image] =>[orig_patent_app_number] => 11816508
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/816508 | Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound | Feb 15, 2006 | Issued |
Array
(
[id] => 5678546
[patent_doc_number] => 20060183902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Dihydroindolyl methanones as alpha 1a/1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms'
[patent_app_type] => utility
[patent_app_number] => 11/353581
[patent_app_country] => US
[patent_app_date] => 2006-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16356
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183902.pdf
[firstpage_image] =>[orig_patent_app_number] => 11353581
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/353581 | Dihydroindolyl methanones as alpha 1a/1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms | Feb 13, 2006 | Abandoned |
Array
(
[id] => 5620092
[patent_doc_number] => 20060189626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Bi-pyridinyl derivatives as NK-1 antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/353307
[patent_app_country] => US
[patent_app_date] => 2006-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5472
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189626.pdf
[firstpage_image] =>[orig_patent_app_number] => 11353307
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/353307 | Bi-pyridinyl derivatives as NK-1 antagonists | Feb 13, 2006 | Issued |
Array
(
[id] => 4786236
[patent_doc_number] => 20080139565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia'
[patent_app_type] => utility
[patent_app_number] => 11/815349
[patent_app_country] => US
[patent_app_date] => 2006-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11908
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139565.pdf
[firstpage_image] =>[orig_patent_app_number] => 11815349
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/815349 | Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia | Feb 13, 2006 | Abandoned |
Array
(
[id] => 535658
[patent_doc_number] => 07176207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-13
[patent_title] => 'Platelet adenosine diphosphate receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/347768
[patent_app_country] => US
[patent_app_date] => 2006-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65853
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/176/07176207.pdf
[firstpage_image] =>[orig_patent_app_number] => 11347768
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/347768 | Platelet adenosine diphosphate receptor antagonists | Feb 1, 2006 | Issued |
Array
(
[id] => 132963
[patent_doc_number] => 07696208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-13
[patent_title] => 'Therapeutic agents useful for treating pain'
[patent_app_type] => utility
[patent_app_number] => 11/344937
[patent_app_country] => US
[patent_app_date] => 2006-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32347
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/696/07696208.pdf
[firstpage_image] =>[orig_patent_app_number] => 11344937
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/344937 | Therapeutic agents useful for treating pain | Jan 30, 2006 | Issued |
Array
(
[id] => 505523
[patent_doc_number] => 07202248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-10
[patent_title] => 'Inhibitors of macrophage migration inhibitory factor and methods for identifying the same'
[patent_app_type] => utility
[patent_app_number] => 11/344938
[patent_app_country] => US
[patent_app_date] => 2006-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 41959
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/202/07202248.pdf
[firstpage_image] =>[orig_patent_app_number] => 11344938
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/344938 | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same | Jan 30, 2006 | Issued |
Array
(
[id] => 4475475
[patent_doc_number] => 07868009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-11
[patent_title] => 'N-hydroxyamide derivatives and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/883286
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13783
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/868/07868009.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883286
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883286 | N-hydroxyamide derivatives and use thereof | Jan 26, 2006 | Issued |
Array
(
[id] => 680142
[patent_doc_number] => 07084142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-01
[patent_title] => 'Platelet adenosine diphosphate receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/331621
[patent_app_country] => US
[patent_app_date] => 2006-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23486
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/084/07084142.pdf
[firstpage_image] =>[orig_patent_app_number] => 11331621
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/331621 | Platelet adenosine diphosphate receptor antagonists | Jan 11, 2006 | Issued |
Array
(
[id] => 5754675
[patent_doc_number] => 20060223824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Serotonergic agents'
[patent_app_type] => utility
[patent_app_number] => 11/330907
[patent_app_country] => US
[patent_app_date] => 2006-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3083
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223824.pdf
[firstpage_image] =>[orig_patent_app_number] => 11330907
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/330907 | Serotonergic agents | Jan 10, 2006 | Abandoned |
Array
(
[id] => 5875328
[patent_doc_number] => 20060167009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Monocyclic substituted phenyl methanones'
[patent_app_type] => utility
[patent_app_number] => 11/324990
[patent_app_country] => US
[patent_app_date] => 2006-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23778
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20060167009.pdf
[firstpage_image] =>[orig_patent_app_number] => 11324990
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/324990 | Monocyclic substituted phenyl methanones | Jan 2, 2006 | Issued |
Array
(
[id] => 5632592
[patent_doc_number] => 20060149062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Sulfanyl substituted phenyl methanones'
[patent_app_type] => utility
[patent_app_number] => 11/324991
[patent_app_country] => US
[patent_app_date] => 2006-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8940
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20060149062.pdf
[firstpage_image] =>[orig_patent_app_number] => 11324991
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/324991 | Sulfanyl substituted phenyl methanones | Jan 2, 2006 | Abandoned |
Array
(
[id] => 4720143
[patent_doc_number] => 20080242666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => '1-6-Substituted (3R,6R)-3-(2,3-Dihydro-1H-Inden-2-Yl)-2,5-Piperazinedione Derivatives as Oxytocin Receptor Antagonists For the Treatment of Preterm Labour, Dysmenorrhea and Endometriosis'
[patent_app_type] => utility
[patent_app_number] => 11/722732
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49050
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242666.pdf
[firstpage_image] =>[orig_patent_app_number] => 11722732
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/722732 | 1-6-Substituted (3R,6R)-3-(2,3-Dihydro-1H-Inden-2-Yl)-2,5-Piperazinedione Derivatives as Oxytocin Receptor Antagonists For the Treatment of Preterm Labour, Dysmenorrhea and Endometriosis | Dec 21, 2005 | Abandoned |
Array
(
[id] => 7762512
[patent_doc_number] => 08114875
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-14
[patent_title] => 'Substituted N-heterocyclic compounds and their use as dopamine D3 receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 11/793633
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25405
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/114/08114875.pdf
[firstpage_image] =>[orig_patent_app_number] => 11793633
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793633 | Substituted N-heterocyclic compounds and their use as dopamine D3 receptor ligands | Dec 19, 2005 | Issued |
Array
(
[id] => 5808362
[patent_doc_number] => 20060094717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/304183
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18905
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094717.pdf
[firstpage_image] =>[orig_patent_app_number] => 11304183
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/304183 | Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives | Dec 14, 2005 | Abandoned |